Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2002 | 06-2002 | 03-2002 | 12-2001 | 09-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,692 | -5,500 | -21,193 | -16,061 | -10,741 |
| Depreciation Amortization | 992 | 497 | 1,771 | 1,408 | 943 |
| Accounts receivable | 1,500 | 524 | 1,521 | 3,063 | 3,317 |
| Accounts payable and accrued liabilities | -927 | -724 | -154 | 506 | -95 |
| Other Working Capital | -537 | -1,872 | -586 | 1,820 | 1,704 |
| Other Operating Activity | -405 | 233 | -971 | -3,473 | -3,126 |
| Operating Cash Flow | $-10,069 | $-6,842 | $-19,612 | $-12,737 | $-7,998 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 13,385 | 14,690 | -23,618 | -34,233 | -30,108 |
| PPE Investments | -546 | -215 | -1,624 | -1,241 | -820 |
| Purchase Sale Intangibles | -97 | -39 | -441 | -406 | -237 |
| Other Investing Activity | -97 | -39 | -441 | -406 | -237 |
| Investing Cash Flow | $12,742 | $14,436 | $-25,683 | $-35,880 | $-31,165 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -40 | -20 | -492 | -473 | -454 |
| Common Stock Issued | 295 | 61 | 992 | 830 | 761 |
| Financing Cash Flow | $255 | $41 | $500 | $357 | $307 |
| Beginning Cash Position | 45,667 | 45,667 | 90,462 | 90,462 | 90,462 |
| End Cash Position | 48,595 | 53,302 | 45,667 | 42,202 | 51,606 |
| Net Cash Flow | $2,928 | $7,635 | $-44,795 | $-48,260 | $-38,856 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,069 | -6,842 | -19,612 | -12,737 | -7,998 |
| Capital Expenditure | -546 | -215 | -1,624 | -1,241 | -820 |
| Free Cash Flow | -10,615 | -7,057 | -21,236 | -13,978 | -8,818 |